![]() |
Originally Posted by 8420PR
(Post 33159479)
And the UK has just said for people under 30 the risks outweigh the benefits. Below is Jonathan Van-Tam's slide he just presented:
https://cimg1.ibsrv.net/gimg/www.fly...bdc6780bc1.png |
Originally Posted by Misco60
(Post 33159284)
The UK ordered a total of 457 million doses from 8 different manufacturers, of which only 100 million were AZ. I really don't think that can be considered to be one basket.
It just so happened that the AZ vaccine was one of the first actually available and the one that has been administered the most, which isn't the same thing. I'm pointing out that over the next two months AZ makes up the vast majority of first doses and the loss of it would delay the July date for everyone to be offered a first dose. The orders for other vaccines are irrelevant until they are approved and available. |
Australian Covid vaccine rollout to continue after blood clot case in Melbourne
"Australia’s acting chief medical officer says there will be no changes to the national vaccination program for Covid-19 while health authorities continue to investigate whether blood clots developed by a 44-year-old Victorian man are linked to the AstraZeneca jab." He doesn't seem to fit the <30 narrative. There's probably more risk in this world due to obesity and heart disease, so let's ban food. It really doesn't sound as though they have enough data to hand to be definitive as to what this "rarity" is. |
Originally Posted by alex67500
(Post 33159561)
Interesting, and actually much more worrying than I initially thought. Does anybody know why the risks get lower with higher age? I thought older people were more at risk of clotting in the first place?
Let's also take into effect as they have that young people don't really need the vaccine to protect themselves too much as very low risk of issues for them, it's more for herd immunity/protecting community purposes. More importantly cases very low today as well as UK is close to herd immunity from vaccinations + immunity. And for all intents and purposes, lockdown is essentially over as of next Monday (hopefully the weather improves by then!). I think the high streets will look much more normal as of Monday, and I will be out and about to check that out. |
|
1 Attachment(s)
Originally Posted by Misco60
(Post 33159129)
The UK's eggs were not all "put in one basket": we've ordered vaccines from several manufacturers.
And I think it's clear that the UK's strategy - some said gamble - has paid off handsomely, with infections, hospitalisations and deaths down by 95% while mainland Europe suffers a new wave and a vaccine shortage. |
Originally Posted by ahmetdouas
(Post 33159649)
And for all intents and purposes, lockdown is essentially over as of next Monday...
|
Originally Posted by slicktony
(Post 33159692)
I wouldn't dispute the vaccine roll-out has been going well (not least because I'm due to get my first shot tomorrow! Woo-hoo!) But on the difference between the UK and the EU in terms of infections, I wouldn't overlook the spread of the B.1.1.7 strain, as illustrated by this graphic from the FT. It might simply be that some of those countries struggling at the moment are doing so because the spread of the more contagious variant which scared those of us in the UK so badly at the beginning of the year has in the past month has really caught fire across the continent.
|
Originally Posted by LGWClosedAgain
(Post 33159565)
I only included approved vaccines, which AZ makes up 64% of the 157 million doses and most (all maybe?) of the remaining Pfizer doses are second doses.
I'm pointing out that over the next two months AZ makes up the vast majority of first doses and the loss of it would delay the July date for everyone to be offered a first dose. The orders for other vaccines are irrelevant until they are approved and available. |
Originally Posted by TomMM
(Post 33159738)
Do they break that out by age. I read a story here in the US that a higher percentage of younger people are being infected with the variants.
What's really interesting I think is that it suggests that the UK may really benefit from the timing of the roll-out and the fact that vaccine levels are reaching critical mass at a point when infection rates are at a low - it will take much longer in some European states for the impact of vaccination to really start taking effect because of where they are starting from. I'm genuinely hopeful that the worst may be over in the UK, for the moment at least. The fact that vaccine distribution is so uneven across the world and the potential for resistant strains to spring up in part as a result is the thing that gives me the most concern in the coming months. Not least, the implications that may have on travel... which is... after all... why we are all here! |
Originally Posted by chimichanga
(Post 33159752)
Are there any stats available that break down how many Pfizer/BioNTech vs AZ vaccine doses have been administered in the UK?
The link for tracking which vaccine is used has been dead for a couple of weeks. |
The Scotland database lets you look at AZ vs Pfizer administered doses so you can see it for Scotland. There is no Moderna yet so I guess SCO has not started with it yet.
It also splits by dose 1 or dose 2. https://public.tableau.com/profile/p...43010/Overview The vaccinations tab. |
Originally Posted by Dan1113
(Post 33159934)
The Scotland database lets you look at AZ vs Pfizer administered doses so you can see it for Scotland. There is no Moderna yet so I guess SCO has not started with it yet.
It also splits by dose 1 or dose 2. https://public.tableau.com/profile/p...43010/Overview The vaccinations tab. Wish they had that kind of dashboard for England too |
Originally Posted by LGWClosedAgain
(Post 33159565)
I'm pointing out that over the next two months AZ makes up the vast majority of first doses and the loss of it would delay the July date for everyone to be offered a first dose. The orders for other vaccines are irrelevant until they are approved and available.
|
Originally Posted by corporate-wage-slave
(Post 33160002)
There isn't going to be a loss of AZ from the vaccine programme, merely a reconfiguration of rollout strategy. That is based on what we know now. Novavax is expected to be approved shortly, and then J&J. Right now the July date - for vaccines to everyone over 16 / 18 years old, is looking more plausible rather than less. The new people getting AZ today were in the 40s on the whole.
|
| All times are GMT -6. The time now is 5:46 am. |
This site is owned, operated, and maintained by MH Sub I, LLC dba Internet Brands. Copyright © 2026 MH Sub I, LLC dba Internet Brands. All rights reserved. Designated trademarks are the property of their respective owners.